• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-410是上皮-间质转化的关键调节因子,在前列腺癌中具有双相作用。

miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer.

作者信息

Asante Diana M, Sreekumar Amritha, Nathani Sandip, Lee Tae Jin, Sharma Ashok, Patel Nikhil, Simmons Matthew N, Saini Sharanjot

机构信息

Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA 30912, USA.

Department of Center for Biotechnology and Genomic Medicine, Augusta University, Augusta, GA 30912, USA.

出版信息

Cancers (Basel). 2023 Dec 21;16(1):48. doi: 10.3390/cancers16010048.

DOI:10.3390/cancers16010048
PMID:38201476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10777946/
Abstract

The molecular basis of prostate cancer (PCa) progression from the primary disease to metastatic castration-resistant prostate cancer (CRPC) followed by therapy-induced neuroendocrine prostate cancer is not fully understood. In this study, we elucidate the role of miR-410, a little-studied microRNA located on chromosome 14q32.31 within the DLK1-DIO3 cluster, in PCa. miR-410 expression analyses in primary and metastatic PCa tissues and cell lines show that its levels are decreased in initial stages and increased in advanced PCa. Functional studies were performed in a series of PCa cell lines. In LNCaP cells, miR-410 overexpression led to decreases in cellular viability, proliferation, invasiveness, and migration. On the other hand, miR-410 overexpression in PC3 and C42B cells led to increased viability, proliferation, and invasiveness. Our data suggest that miR-410 represses epithelial-to-mesenchymal transition (EMT) in LNCaP cells by directly repressing SNAIL. However, it promotes EMT and upregulates PI3K/Akt signaling in PC3 and C42B cells. In vivo studies with PC3 xenografts support an oncogenic role of miR-410. These data suggest that miR-410 acts as a tumor suppressor in the initial stages of PCa and play an oncogenic role in advanced PCa. Our findings have important implications in understanding the molecular basis of PCa progression with potential translational implications.

摘要

前列腺癌(PCa)从原发性疾病进展为转移性去势抵抗性前列腺癌(CRPC),随后发展为治疗诱导的神经内分泌前列腺癌的分子基础尚未完全明确。在本研究中,我们阐明了miR-410在PCa中的作用,miR-410是位于14q32.31染色体上DLK1-DIO3簇内一个研究较少的微小RNA。对原发性和转移性PCa组织及细胞系进行的miR-410表达分析表明,其水平在PCa初期降低,在晚期升高。在一系列PCa细胞系中进行了功能研究。在LNCaP细胞中,miR-410过表达导致细胞活力、增殖、侵袭和迁移能力下降。另一方面,PC3和C42B细胞中miR-410过表达导致活力、增殖和侵袭能力增强。我们的数据表明,miR-410通过直接抑制SNAIL来抑制LNCaP细胞中的上皮-间质转化(EMT)。然而,它在PC3和C42B细胞中促进EMT并上调PI3K/Akt信号通路。对PC3异种移植瘤的体内研究支持了miR-410的致癌作用。这些数据表明,miR-410在PCa初期起肿瘤抑制作用,而在晚期PCa中发挥致癌作用。我们的研究结果对于理解PCa进展的分子基础具有重要意义,并具有潜在的转化意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/966d2d5e2cfe/cancers-16-00048-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/58a65a037b4a/cancers-16-00048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/0225f11c44c9/cancers-16-00048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/5be138a00af0/cancers-16-00048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/b1014f077a42/cancers-16-00048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/9064245944cf/cancers-16-00048-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/873f82228c33/cancers-16-00048-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/47a8bfc5f179/cancers-16-00048-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/46e824e5a82d/cancers-16-00048-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/966d2d5e2cfe/cancers-16-00048-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/58a65a037b4a/cancers-16-00048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/0225f11c44c9/cancers-16-00048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/5be138a00af0/cancers-16-00048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/b1014f077a42/cancers-16-00048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/9064245944cf/cancers-16-00048-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/873f82228c33/cancers-16-00048-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/47a8bfc5f179/cancers-16-00048-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/46e824e5a82d/cancers-16-00048-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e1/10777946/966d2d5e2cfe/cancers-16-00048-g009.jpg

相似文献

1
miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer.miR-410是上皮-间质转化的关键调节因子,在前列腺癌中具有双相作用。
Cancers (Basel). 2023 Dec 21;16(1):48. doi: 10.3390/cancers16010048.
2
A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.一种新型的前列腺癌上皮-间质转化的微小RNA调节因子。
Cell Death Differ. 2017 Jul;24(7):1263-1274. doi: 10.1038/cdd.2017.69. Epub 2017 May 12.
3
miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.DLK1-DIO3微小RNA大簇中的miR-154*和miR-379调节前列腺癌的上皮-间质转化和骨转移。
Clin Cancer Res. 2014 Dec 15;20(24):6559-69. doi: 10.1158/1078-0432.CCR-14-1784. Epub 2014 Oct 16.
4
MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.MicroRNA-132/212上调通过靶向SOX4抑制转化生长因子-β介导的前列腺癌细胞上皮-间质转化
Prostate. 2016 Dec;76(16):1560-1570. doi: 10.1002/pros.23241. Epub 2016 Aug 16.
5
MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.微小 RNA-498 通过靶向 PTEN 促进前列腺癌细胞的增殖、迁移和侵袭,并降低其辐射敏感性。
Kaohsiung J Med Sci. 2019 Nov;35(11):659-671. doi: 10.1002/kjm2.12108. Epub 2019 Jul 22.
6
Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer.miR-99b-5p与恩杂鲁胺或阿比特龙联合使用可协同抑制前列腺癌中EMT介导的转移。
Cancers (Basel). 2024 May 19;16(10):1933. doi: 10.3390/cancers16101933.
7
microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.微小RNA-802通过靶向人前列腺癌中的 flotillin-2抑制上皮-间质转化
Biosci Rep. 2017 Mar 15;37(2). doi: 10.1042/BSR20160521. Print 2017 Apr 30.
8
miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition.微小RNA-486-5p通过靶向Snail并调节上皮-间质转化来抑制前列腺癌转移。
Onco Targets Ther. 2016 Nov 8;9:6909-6914. doi: 10.2147/OTT.S117338. eCollection 2016.
9
Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.长链非编码 RNA DANCR 通过靶向 miR-185-5p 上调 LIM 和 SH3 蛋白 1,通过 FAK/PI3K/AKT/GSK3β/snail 通路促进前列腺癌。
J Gene Med. 2021 Jul;23(7):e3344. doi: 10.1002/jgm.3344. Epub 2021 May 5.
10
Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.微小RNA-214-3p的敲低促进前列腺癌的肿瘤生长和上皮-间质转化
Cancers (Basel). 2021 Nov 23;13(23):5875. doi: 10.3390/cancers13235875.

引用本文的文献

1
Magnetic hyperthermia-based therapies for cancer targeting: current progress and future perspectives.基于磁热疗的癌症靶向治疗:当前进展与未来展望。
Med Oncol. 2025 Aug 28;42(10):453. doi: 10.1007/s12032-025-03020-9.
2
From unipotency to pluripotency: deciphering protein networks and signaling pathways in the generation of embryonic stem-like cells from murine spermatogonial stem cells.从单能性到多能性:解析从小鼠精原干细胞生成胚胎干细胞样细胞过程中的蛋白质网络和信号通路。
BMC Genomics. 2025 Apr 30;26(1):426. doi: 10.1186/s12864-025-11612-y.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Role of MicroRNAs in Neuroendocrine Prostate Cancer.微小RNA在神经内分泌前列腺癌中的作用
Noncoding RNA. 2022 Mar 30;8(2):25. doi: 10.3390/ncrna8020025.
3
UALCAN: An update to the integrated cancer data analysis platform.UALCAN:一个集成癌症数据分析平台的更新。
Neoplasia. 2022 Mar;25:18-27. doi: 10.1016/j.neo.2022.01.001. Epub 2022 Jan 22.
4
MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer.微小RNA在前列腺癌治疗诱导的神经内分泌分化中的作用
Cancer Drug Resist. 2020;3(4):804-818. doi: 10.20517/cdr.2020.30. Epub 2020 Oct 12.
5
The biochemical basis of microRNA targeting efficacy.miRNA 靶向疗效的生化基础。
Science. 2019 Dec 20;366(6472). doi: 10.1126/science.aav1741. Epub 2019 Dec 5.
6
Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways.通过 MAPK、PTEN/AKT 和 STAT3 信号通路,miR-410-3p 在促性腺激素和促皮质激素垂体腺瘤中作为癌基因,或在生长激素腺瘤中作为肿瘤抑制 miR,具有谱系依赖性作用。
Endocrine. 2019 Sep;65(3):646-655. doi: 10.1007/s12020-019-01960-7. Epub 2019 Jun 4.
7
MicroRNAs as Regulators of Prostate Cancer Metastasis.微小 RNA 作为前列腺癌转移的调控因子。
Adv Exp Med Biol. 2018;1095:83-100. doi: 10.1007/978-3-319-95693-0_5.
8
Role of microRNA-410 in molecular oncology: A double edged sword.miRNA-410 在分子肿瘤学中的作用:一把双刃剑。
J Cell Biochem. 2018 Nov;119(11):8737-8742. doi: 10.1002/jcb.27251. Epub 2018 Aug 7.
9
miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.miR-410-3p 通过调控 PTEN/AKT/mTOR 信号通路促进前列腺癌进展。
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2459-2465. doi: 10.1016/j.bbrc.2018.06.176. Epub 2018 Jul 6.
10
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer.前列腺癌中恩杂鲁胺耐药的分子机制
Curr Mol Biol Rep. 2017;3(4):230-235. doi: 10.1007/s40610-017-0079-1. Epub 2017 Oct 23.